Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

404 ARTÍCULOS , VIENDO DEL 376 AL 390

Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Piñero E.

Crit Rev Clin Lab Sci. 2021 May;58(3):167-179. doi: 10.1080/10408363.2020.1833298. Epub 2020 Nov 2.

A Multilevel View of the Development of Alzheimer's Disease

Avila J, Perry G.

Neuroscience. 2021 Mar 1;457:283-293. doi: 10.1016/j.neuroscience.2020.11.015. Epub 2020 Nov 24.

Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis

Chaudhry A, Rizig M.

J Neurol Sci. 2021 Feb 15;421:117270. doi: 10.1016/j.jns.2020.117270. Epub 2020 Dec 15.

Inclusion of ethnoracial populations and diversity remains a key challenge in Alzheimer's disease biofluid-based biomarker studies

Babulal GM.

J Neurol Sci. 2021 Feb 15;421:117269. doi: 10.1016/j.jns.2020.117269. Epub 2020 Dec 14.

European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment

Frederiksen KS, Nielsen TR, Winblad B, Schmidt R, Kramberger MG, Jones RW, Hort J, Grimmer T, Georges J, Frölich L, Engelborghs S, Dubois B, Waldemar G.

Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.

Blood biomarkers in Alzheimer's disease

Altuna-Azkargorta M, Mendioroz-Iriarte M.

Neurologia (Engl Ed). 2021 Nov-Dec;36(9):704-710. doi: 10.1016/j.nrleng.2018.03.006. Epub 2020 Feb 19.

What does diagnostic threshold mean? Deterministic and probabilistic considerations

Nakajima K, Okuda K, Komatsu J.

J Nucl Cardiol. 2021 Aug;28(4):1702-1706. doi: 10.1007/s12350-019-01899-2. Epub 2019 Sep 23.

Signs and symptoms method in neuropsychology: A preliminary investigation of a standardized clinical interview for assessment of cognitive decline in dementia

Abbate C, Trimarchi PD, Inglese S, Tomasini E, Bagarolo R, Giunco F, Cesari M.

Appl Neuropsychol Adult. 2021 May-Jun;28(3):282-296. doi: 10.1080/23279095.2019.1630626. Epub 2019 Jul 3.

Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging

Yan Q, Nho K, Del-Aguila JL, Wang X, Risacher SL, Fan KH, Snitz BE, Aizenstein HJ, Mathis CA, Lopez OL, Demirci FY, Feingold E, Klunk WE, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Cruchaga C, Kamboh MI.

Mol Psychiatry. 2021 Jan;26(1):309-321. doi: 10.1038/s41380-018-0246-7. Epub 2018 Oct 25.

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases

Mayo S, Benito-León J, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

Curr Neuropharmacol. 2021;19(8):1273-1303. doi: 10.2174/1570159X19666201223154009.

An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology

Tando S, Kasai T, Mizuta I, Takahashi H, Yaoi T, Saito K, Hojo T, Mizuno T, Hasegawa M, Itoh K.

Neuropathology. 2021 Jun;41(3):214-225. doi: 10.1111/neup.12723. Epub 2021 Feb 3.

Electrochemical biosensors for biometal-protein interactions in neurodegenerative diseases

Li S, Kerman K.

Biosens Bioelectron. 2021 May 1;179:113035. doi: 10.1016/j.bios.2021.113035. Epub 2021 Jan 26.

Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression

Krokidis MG, Exarchos TP, Vlamos P.

Math Biosci Eng. 2021 Feb 22;18(2):1813-1832. doi: 10.3934/mbe.2021094.

Multimodal Imaging in a Patient With Alzheimer Disease and Parkinsonism Because of a Presenilin-1 Mutation

Lu JY, Sun YM, Yen TC, Zuo CT, Wang J.

Clin Nucl Med. 2021 Sep 1;46(9):e483-e484. doi: 10.1097/RLU.0000000000003674.

Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders

Chalkias IN, Tegos T, Topouzis F, Tsolaki M.

Eur J Ophthalmol. 2021 Nov;31(6):2808-2817. doi: 10.1177/11206721211016311. Epub 2021 May 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias